Company intelligence / Profile preview
SwiftPharma
Ghent (Gent), Oost-Vlaanderen (Flanders), Belgiumswiftpharma.eu ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Successfully manufactured a virus inhibitor protein for preventing HIV transmission in Medace's cleanroom facility; working on biosimilar protein for reducing the cost of oncology treatments
- Therapeutic areas
- OncologyRare DiseasesInfectious Diseases
- Modalities
- Recombinant proteinsvaccinesmonoclonal antibodiescytokinesenzymesantiviralsantibacterial agentshormoneshematopoietic growth factorsartificial blood substituteshuman recombinant collagen
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
PlantForm CorporationPopulation CouncilNational Institutes of Health (NIH)Bio-Manguinhos (Brazil Ministry of Health)ArthrocartMedace
Beyond the preview
Go deeper on SwiftPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SwiftPharma.